Validation of a rapid SARS-CoV-2 antibody test in general practice.

ABSTRACT:

Objectives

To validate a rapid serological test (RST) for SARS-CoV-2 antibodies used in seroprevalence studies in healthcare providers, including primary healthcare providers (PHCPs) in Belgium.

Design

A phase III validation study of the RST (OrientGene) within a prospective cohort study.

Setting

Primary care in Belgium.

Participants

Any general practitioner (GP) working in primary care in Belgium and any other PHCP from the same GP practice who physically manages patients were eligible in the seroprevalence study. For the validation study, all participants who tested positive (376) on the RST at the first testing timepoint (T1) and a random sample of those who tested negative (790) and unclear (24) were included.

Intervention

At T2, 4 weeks later, PHCPs

SUBMITTER: Domen J 

PROVIDER: S-EPMC10163333 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature